Gain TherapeuticsGANX

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Mr. Matthias Alder

$32.2M

Market Cap • 18/06/2024

2020

(há 4 anos)
Fundação

2021

(3 years ago)
IPO

NASDAQ

Listagem
Flag of US

Bethesda

Sede • Maryland

31

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

GANXSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-47%

1 semana

11/06/2024

-49%

1 mês

20/05/2024

-74%

1 ano

20/06/2023

10 anos

Histórico